eXoZymes develops AI-driven approach to produce rare nutraceutical compound
eXoZymes, a leader in AI-engineered enzymes, announced the creation of NCTx, LLC. This new subsidiary will develop and produce N-trans-caffeoyltyramine (NCT), a rare plant-based compound. NCT shows promise for metabolic…
SEOULTECH researchers develop bioink for tissue repair
Researchers at Seoul National University of Science and Technology (SEOULTECH) have developed a bioink made from nanocellulose derived from Kombucha SCOBY. This bioink can be applied directly to damaged tissue…
Researchers develop 3D bioprinter for plant-based pharmaceutical production
A group of 10 undergraduate students from the University of Rochester have developed an affordable 3D-bioprinting system to replicate chemicals found in endangered and non-endangered plant species, which are threatened…